Biocryst Pharmaceuticals (BCRX) Accumulated Expenses (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) reported Accumulated Expenses of $121.9 million for Q2 2026, up 13.8% from $107.11 million a year earlier and up 2.1% from the prior quarter.
Biocryst Pharmaceuticals (BCRX) Accumulated Expenses (2010 - 2026) Analysis & Trends
At the end of FY2025, Biocryst Pharmaceuticals posted Accumulated Expenses of $126.41 million, up 11.6% from FY2024.
- Accumulated Expenses has increased for nine consecutive years, with a five-year compound annual growth rate of 30.1% (FY2020 to FY2025).
- By year, Accumulated Expenses came in at $113.29 million in FY2024 (+10.1%), $102.88 million in FY2023 (+17.5%), $87.57 million in FY2022 (+20.5%) and $72.67 million in FY2021 (+114.1%).
- Five-year quarterly Accumulated Expenses spans a low of $56.31 million in Q3 2021 and a high of $126.41 million in Q4 2025.
- Year over year, Accumulated Expenses has now increased in each of the last 12 quarters, with growth averaging 18.7% over the last eight quarters.
- The high point for year-over-year Accumulated Expenses in five years was Q4 2021 (growth of 114.1%); the low point was Q2 2023 (a decline of 5.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $119.4 million (Q1 2026), $126.41 million (Q4 2025) and $118.78 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biocryst Pharmaceuticals | 2.13 Bn | 1.05 Bn | 214.41 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 121.90 Mn |
| Mar 31, 2026 | 119.40 Mn |
| Dec 31, 2025 | 126.41 Mn |
| Sep 30, 2025 | 118.78 Mn |
| Jun 30, 2025 | 107.11 Mn |
| Mar 31, 2025 | 92.64 Mn |
| Dec 31, 2024 | 113.29 Mn |
| Sep 30, 2024 | 104.20 Mn |
| Jun 30, 2024 | 89.60 Mn |
| Mar 31, 2024 | 79.25 Mn |
| Dec 31, 2023 | 102.88 Mn |
| Sep 30, 2023 | 77.39 Mn |
| Jun 30, 2023 | 75.30 Mn |
| Mar 31, 2023 | 75.21 Mn |
| Dec 31, 2022 | 87.57 Mn |
| Sep 30, 2022 | 69.27 Mn |
| Jun 30, 2022 | 79.71 Mn |
| Mar 31, 2022 | 63.58 Mn |
| Dec 31, 2021 | 72.67 Mn |
| Sep 30, 2021 | 56.31 Mn |
Biocryst Pharmaceuticals Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();